Skip to main content
Screener/Healthcare/Biotechnology

KALV — KalVista Pharmaceuticals, Inc.

NASDAQ
$19.57+0.50 (+2.62%)
Small CapUnder $20HealthcareHigh ROE
$9.83
$21.31
$18.66
$19.65
EPS (TTM)$-3.20
P/E Ratio—
Dividend Yield—
Market Cap$1.03B
Volume686K
Prev Close$19.08
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q3 '26$59.9M-$5.4M$-0.1190.4%-9.0%
Q2 '26$13.7M-$49.5M$-0.9291.0%-361.4%
Q1 '26$1.4M-$60.1M$-1.1258.6%-4214.3%
Q4 '25$0-$52.2M$-1.05——
Q3 '25$0-$48.5M$-0.92——
Q2 '25$0-$42.3M$-0.91——
Q1 '25$0-$40.4M$-0.87——
Q4 '24$0-$44.6M$-1.02——
Get Your Daily Market Recap